Clinical Vignettes™: Integrating Novel CAR T-Cell Therapies Across Lymphoid Malignancies with an Eye Toward the Future of Care
Clinical Vignettes™: Integrating Novel CAR T-Cell Therapies Across Lymphoid Malignancies with an Eye Toward the Future of Care is organized by Physicians' Education Resource, LLC (PER).
Release Date: March 31, 2023
Expiration Date: March 31, 2024
Description:
The recent approval of CD19-targeting CAR T-cell therapies for several relapsed/refractory lymphoid malignancies has energized the field; however, several challenges remain, and a plethora of clinical research is ongoing to discover new drug targets and therapeutic approaches.
This Clinical Case Vignette Series™ program provides a review of current and emerging CAR T-cell therapies in lymphoid malignancies, including B-cell acute lymphoblastic leukemia (B-ALL), diffuse large B-cell lymphoma (DLBCL), and follicular lymphoma (FL). This unique and engaging multimedia activity consists of expert interviews on challenging clinical cases and other topics important to the practicing clinician. Several clinical vignettes are discussed, and an expert provides evidence-based strategies, as well as discussion about current clinical data that are changing outcomes for patients with lymphoid malignancies.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Describe the unique properties and mechanism of action of CAR T-cell therapy
• Assess the latest efficacy and safety data from clinical trials evaluating CAR T-cell therapies in lymphoid malignancies
• Implement proactive multidisciplinary strategies to monitor and manage CAR T-cell therapy associated toxicities
• Apply practice-changing evidence on CAR T-cell therapy to clinical scenarios of patients with lymphoid malignancies.